Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy

被引:8
|
作者
Zis, Panagiotis [1 ]
McHugh, Patrick C. [2 ,3 ]
Manca, Maurizio [2 ,3 ]
Sarrigiannis, Ptolemaios Georgios [1 ]
Rao, Dasappaiah Ganesh [1 ]
Hadjivassiliou, Marios [1 ]
机构
[1] Royal Hallamshire Hosp, Acad Dept Neurosci, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England
[2] Univ Huddersfield, Sch Appl Sci, Ctr Biomarker Res, Huddersfield HD1 3DH, W Yorkshire, England
[3] Univ Huddersfield, Sch Appl Sci, Dept Pharm, Huddersfield HD1 3DH, W Yorkshire, England
关键词
Chronic idiopathic axonal polyneuropathy; CIAP; Gluten neuropathy; Pathogenesis; Oxidative stress; DOWN-SYNDROME; NEUROPATHY;
D O I
10.1007/s12031-018-1200-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic idiopathic axonal polyneuropathy (CIAP) is a disorder with insidious onset and slow progression, where no etiology is identified despite appropriate investigations. We aimed to investigate the role of oxidative stress as a risk factor for the pathogenesis of CIAP. Sera of patients with CIAP were tested for protein carbonyl (PC) and 8-hydroxydeoxyguanosine (8H). As a control group, we recruited patients with gluten neuropathy. Twenty-one patients with CIAP and 21 controls were recruited. The two groups did not differ significantly regarding demographics or clinical characteristics (i.e., neuropathy type or disease severity). After adjusting for gender, having CIAP was positively correlated with both the 8H titer (standardized beta coefficient 0.349, p=0.013) and the PC titer (standardized beta coefficient 0.469, p=0.001). Oxidative stress appears to be increased in CIAP and might have a role in the pathogenesis of the disease.
引用
收藏
页码:547 / 551
页数:5
相关论文
共 50 条
  • [1] Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy
    Panagiotis Zis
    Patrick C. McHugh
    Maurizio Manca
    Ptolemaios Georgios Sarrigiannis
    Dasappaiah Ganesh Rao
    Marios Hadjivassiliou
    Journal of Molecular Neuroscience, 2018, 66 : 547 - 551
  • [2] Chronic idiopathic axonal polyneuropathy
    Notermans, NC
    Wokke, JHJ
    MUSCLE & NERVE, 1996, 19 (12) : 1637 - 1638
  • [3] Chronic idiopathic axonal polyneuropathy revisited
    Rosenberg, NR
    Vermeulen, M
    JOURNAL OF NEUROLOGY, 2004, 251 (09) : 1128 - 1132
  • [4] Chronic idiopathic axonal polyneuropathy - A reply
    Uncini, A
    Lugaresi, A
    Liguori, R
    Montagna, P
    MUSCLE & NERVE, 1996, 19 (12) : 1638 - 1638
  • [5] Chronic idiopathic axonal polyneuropathy revisited
    Nathalie R. Rosenberg
    Marinus Vermeulen
    Journal of Neurology, 2004, 251 : 1128 - 1132
  • [6] Drug therapy for chronic idiopathic axonal polyneuropathy
    Warendorf, Janna
    Vrancken, Alexander F. J. E.
    van Schaik, Ivo N.
    Hughes, Richard A. C.
    Notermans, Nicolette C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [7] Chronic idiopathic axonal polyneuropathy: a systematic review
    Panagiotis Zis
    Ptolemaios Georgios Sarrigiannis
    Dasappaiah Ganesh Rao
    Channa Hewamadduma
    Marios Hadjivassiliou
    Journal of Neurology, 2016, 263 : 1903 - 1910
  • [8] Chronic idiopathic axonal polyneuropathy and glucose tolerance
    Hughes, RAC
    Umapathi, T
    Carey, L
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 230 - 230
  • [9] The role of autoimmunity in chronic idiopathic axonal polyneuropathy
    Zis, P.
    Sarrigiannis, P.
    Rao, D. G.
    Hadjivassiliou, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 678 - 678
  • [10] Chronic axonal idiopathic polyneuropathy: is it really benign
    Samuelsson, Kristin
    Press, Rayomand
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (05) : 562 - 567